Biogénesis Bagó Hong Kong Limited;Biogénesis Bagó Uruguay S.A.
发明人:
BELLINZONI, Rodolfo César,RÉGULIER, Emmanuel Gérard Etienne,ROMO, Ana
申请号：
EP17782018
公开号：
EP3443097A4
申请日:
2017.04.07
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
The present invention relates to a pharmaceutical combination for inducing one or more immune responses and/or for enhancing effectiveness of vaccination in the host, which is capable of inducing cross-protection against multiples strains and/or serotypes of a virus. In one embodiment, the pharmaceutical combination is able to generate protection in food producing animals, such as cattle, sheep, goats, swine and other cloven-hoofed animals with fewer vaccination campaigns. This universal vaccine comprises an inactivated virus with one or more of the following components: polynucleotides encoding viral peptides, polypeptides or proteins in different types of plasmids； viral peptides, polypeptides and proteins； synthetic viral peptides and polypeptides； recombinant viral peptides, polypeptides and proteins； virus-like-particles； virus-like-particles derived from other viruses； proteins used as a carrier or as molecular adjuvant fused to peptides, polypeptides and/or proteins derived from viruses； adjuvants； emulsifiers, molecular adjuvants and carrier systems.
